These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37063883)

  • 1. Challenges and opportunities in analyzing and modeling peptide presentation by HLA-II proteins.
    ElAbd H; Bacher P; Tholey A; Lenz TL; Franke A
    Front Immunol; 2023; 14():1107266. PubMed ID: 37063883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass Spectrometry-Based Immunopeptidomics of Peptides Presented on Human Leukocyte Antigen Proteins.
    ElAbd H; Franke A
    Methods Mol Biol; 2024; 2758():425-443. PubMed ID: 38549028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOF
    Hoenisch Gravel N; Nelde A; Bauer J; Mühlenbruch L; Schroeder SM; Neidert MC; Scheid J; Lemke S; Dubbelaar ML; Wacker M; Dengler A; Klein R; Mauz PS; Löwenheim H; Hauri-Hohl M; Martin R; Hennenlotter J; Stenzl A; Heitmann JS; Salih HR; Rammensee HG; Walz JS
    Nat Commun; 2023 Nov; 14(1):7472. PubMed ID: 37978195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases.
    Prinz JC
    Front Immunol; 2022; 13():1097871. PubMed ID: 36700227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics.
    Lim Kam Sian TCC; Goncalves G; Steele JR; Shamekhi T; Bramberger L; Jin D; Shahbazy M; Purcell AW; Ramarathinam S; Stoychev S; Faridi P
    Front Immunol; 2023; 14():1107576. PubMed ID: 37334365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer.
    Yu Y; Zhang J; Ni L; Zhu Y; Yu H; Teng Y; Lin L; Xue Z; Xue X; Shen X; Song H; Su X; Sun W; Cai Z
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-11. PubMed ID: 33689574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Human Immunopeptidome Project: A Roadmap to Predict and Treat Immune Diseases.
    Vizcaíno JA; Kubiniok P; Kovalchik KA; Ma Q; Duquette JD; Mongrain I; Deutsch EW; Peters B; Sette A; Sirois I; Caron E
    Mol Cell Proteomics; 2020 Jan; 19(1):31-49. PubMed ID: 31744855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of immunopeptidomics: From basic research to clinical implementation.
    Shapiro IE; Bassani-Sternberg M
    Semin Immunol; 2023 Mar; 66():101727. PubMed ID: 36764021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation.
    Jin D; Loh KL; Shamekhi T; Ting YT; Lim Kam Sian TCC; Roest J; Ooi JD; Vivian JP; Faridi P
    Methods Mol Biol; 2023; 2691():351-369. PubMed ID: 37355557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies.
    Taylor HB; Klaeger S; Clauser KR; Sarkizova S; Weingarten-Gabbay S; Graham DB; Carr SA; Abelin JG
    Mol Cell Proteomics; 2021; 20():100116. PubMed ID: 34146720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of antigen-prediction algorithm for personalized neoantigen vaccine using human leukocyte antigen transgenic mouse.
    Charneau J; Suzuki T; Shimomura M; Fujinami N; Mishima Y; Hiranuka K; Watanabe N; Yamada T; Nakamura N; Nakatsura T
    Cancer Sci; 2022 Apr; 113(4):1113-1124. PubMed ID: 35122353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections.
    Juanes-Velasco P; Landeira-Viñuela A; Acebes-Fernandez V; Hernández ÁP; Garcia-Vaquero ML; Arias-Hidalgo C; Bareke H; Montalvillo E; Gongora R; Fuentes M
    Front Cell Infect Microbiol; 2021; 11():642583. PubMed ID: 34123866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies.
    Weitzen M; Shahbazy M; Kapoor S; Caron E
    Front Immunol; 2024; 15():1442783. PubMed ID: 39301027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma.
    Qi YA; Maity TK; Cultraro CM; Misra V; Zhang X; Ade C; Gao S; Milewski D; Nguyen KD; Ebrahimabadi MH; Hanada KI; Khan J; Sahinalp C; Yang JC; Guha U
    Mol Cell Proteomics; 2021; 20():100136. PubMed ID: 34391887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Importance of Being Presented: Target Validation by Immunopeptidomics for Epitope-Specific Immunotherapies.
    Becker JP; Riemer AB
    Front Immunol; 2022; 13():883989. PubMed ID: 35464395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen identification for HLA class I- and HLA class II-restricted T cell receptors using cytokine-capturing antigen-presenting cells.
    Lee MN; Meyerson M
    Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights and approaches for analyses of immunopeptidomes.
    Illing PT; Ramarathinam SH; Purcell AW
    Curr Opin Immunol; 2022 Aug; 77():102216. PubMed ID: 35716458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.
    Freudenmann LK; Marcu A; Stevanović S
    Immunology; 2018 Jul; 154(3):331-345. PubMed ID: 29658117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
    Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
    Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptides presented by HLA class I molecules in the human thymus.
    Espinosa G; Collado JA; Scholz E; Mestre-Ferrer A; Kuse N; Takiguchi M; Carrascal M; Canals F; Pujol-Borrell R; Jaraquemada D; Alvarez I
    J Proteomics; 2013 Dec; 94():23-36. PubMed ID: 24029068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.